PIK3CD and oculocerebrorenal syndrome: The rescue of endocytosis observed when targeting the actin machinery in OCRL patient and knockout (KO) cells,7,10 together with upstream regulation of actin by PI3K activity14 and the highly interconnected nature of PI conversion, provides an intriguing possibility that class I PI3K inhibitors may be of utility in Lowe syndrome.